Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...